Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity
Gliknik Inc.
Gliknik Inc.
University of California, San Francisco
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)